Wei Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Systematic Review

Chemotherapy Induced

High Performance Liquid Chromatography

Top Venues

Cell death & disease

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Hanhui Yao, Delong Ren, Yichun Wang, Liang Wu, Yang Wu, Wei Wang, Qidong Li, Lian-Xin Liu
KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. Cell death & disease 13 (9) (2022)
Wei Wang, Yu-Hao Hao, Yusheng Liu, Rui Li, Da-Bing Huang, Yue-Yin Pan
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 13 (1) (2020)